Equities

Cinkarna Celje dd

CICG:LJU

Cinkarna Celje dd

Actions
Basic MaterialsChemicals
  • Price (EUR)24.80
  • Today's Change-0.600 / -2.36%
  • Shares traded11.18k
  • 1 Year change+2.90%
  • Beta0.9890
Data delayed at least 20 minutes, as of Nov 22 2024 13:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform0
Hold0
Sell1
Strong Sell0

Share price forecast

The one analyst offering a 12 month price target expects Cinkarna Celje dd share price to fall to 20.00 in the next year from the last price of 24.80.
High-19.4%20.00
Med-19.4%20.00
Low-19.4%20.00

Earnings history & estimates in EUR

Cinkarna Celje dd reported annual 2022 earnings of 5.37 per share on Mar 08, 2023.
Average growth rate-29.27%
More ▼

Revenue history & estimates in EUR

Cinkarna Celje, d. d. had 2nd quarter 2023 revenues of 52.81m. This bettered the 46.40m estimate of the one analyst covering the company. This was 36.93% above the prior year's 2nd quarter results.
Average growth rate+6.57%
Cinkarna Celje, d. d. had revenues for the full year 2022 of 227.15m. Last year the company did not report any revenues.
Average growth rate+8.73%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.